Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease
Rawan Tarawneh1, Denise Head2, Samantha L. Allison3, Virginia Buckles4, Anne M. Fagan1, Jack H. Ladenson5, John C. Morris6, David M. Holtzman1
1Department of Neurology, Washington University School of Medicine in St Louis, St Louis, Missouri2Hope Center for Neurological Disorders, Washington University School of Medicine in St Louis, St Louis, Missouri3The Charles F. and Joanne Knight Alzheimer’s
2The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University School of Medicine in St Louis, St Louis, Missouri5Department of Radiology, Washington University School of Medicine in St Louis, St Louis, Missouri6Department of
3Department of Psychology, Washington University School of Medicine in St Louis, St Louis, Missouri.
4Department of Neurology, Washington University School of Medicine in St Louis, St Louis, Missouri3The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University School of Medicine in St Louis, St Louis, Missouri
5Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
6Department of Neurology, Washington University School of Medicine in St Louis, St Louis, Missouri3The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University School of Medicine in St Louis, St Louis, Missouri7Department of
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
JAMA Neurology
Tập 72 Số 6
656
Thông tin tác giả